☰

Jeffrey Bruce, Ph.D. - Publications

Affiliations: 
2014 Medical Biophysics University of Toronto, Toronto, ON, Canada 
Area:
Oncology, Cell Biology, Biomedical Engineering, Molecular Biology
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kwan JYY, Lin LT, Bell R, Bruce JP, Richardson C, Pugh TJ, Liu FF. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients. Scientific Reports. 11: 4533. PMID 33633121 DOI: 10.1038/s41598-021-83366-y  0.445
2020 Bissey PA, Teng M, Law JH, Shi W, Bruce JP, Petit V, Tsao SW, Yip KW, Liu FF. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. Bmc Cancer. 20: 597. PMID 32586280 DOI: 10.1186/S12885-020-07081-Z  0.548
2020 Quevedo R, Spreafico A, Bruce J, Danesh A, El Ghamrasni S, Giesler A, Hanna Y, Have C, Li T, Yang SYC, Zhang T, Asa SL, Haibe-Kains B, Krzyzanowska M, Smith AC, et al. Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor. Genome Medicine. 12: 38. PMID 32345369 DOI: 10.1186/S13073-020-00730-9  0.332
2018 Karamboulas C, Bruce JP, Hope AJ, Meens J, Huang SH, Erdmann N, Hyatt E, Pereira K, Goldstein DP, Weinreb I, Su J, O'Sullivan B, Tiedemann R, Liu FF, Pugh TJ, et al. Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma. Cell Reports. 25: 1318-1331.e4. PMID 30380421 DOI: 10.1016/J.Celrep.2018.10.004  0.474
2018 Su B, Xu T, Bruce JP, Yip KW, Zhang N, Huang Z, Zhang G, Liu FF, Liang J, Yang H, Claret FX. hsa‑miR‑24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c‑Myc/epithelial‑mesenchymal transition axis. Oncology Reports. PMID 30226609 DOI: 10.3892/or.2018.6690  0.537
2018 Bissey PA, Law JH, Bruce JP, Shi W, Renoult A, Chua MLK, Yip KW, Liu FF. Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma. Oncogenesis. 7: 40. PMID 29795279 DOI: 10.1038/s41389-018-0050-x  0.55
2017 Mesci A, Huang X, Taeb S, Jahangiri S, Kim Y, Fokas E, Bruce J, Leong HS, Liu SK. Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis. British Journal of Cancer. PMID 28419078 DOI: 10.1038/Bjc.2017.105  0.492
2016 Bruce JP, Xu W, Liu FF. The KRAS Variant as a Predictive Biomarker of Cetuximab Response in Head and Neck Cancer. Jama Oncology. PMID 28006061 DOI: 10.1001/Jamaoncol.2016.5686  0.435
2016 Spence T, Bruce J, Yip KW, Liu FF. HPV Associated Head and Neck Cancer. Cancers. 8. PMID 27527216 DOI: 10.3390/Cancers8080075  0.472
2016 Spence T, Bruce J, Yip KW, Liu FF. MicroRNAs in nasopharyngeal carcinoma. Chinese Clinical Oncology. 5: 17. PMID 27121877 DOI: 10.21037/Cco.2016.03.09  0.515
2016 Bratman SV, Bruce JP, O'Sullivan B, Pugh TJ, Xu W, Yip KW, Liu FF. Human Papillomavirus Genotype Association With Survival in Head and Neck Squamous Cell Carcinoma. Jama Oncology. PMID 27010835 DOI: 10.1001/Jamaoncol.2015.6587  0.429
2016 Kwan JY, Psarianos P, Bruce JP, Yip KW, Liu FF. The complexity of microRNAs in human cancer. Journal of Radiation Research. PMID 26983984 DOI: 10.1093/Jrr/Rrw009  0.463
2016 Shi W, Bruce J, Lee M, Yue S, Rowe M, Pintilie M, Kogo R, Bissey PA, Fyles A, Yip KW, Liu FF. MiR-449a promotes breast cancer progression by targeting CRIP2. Oncotarget. PMID 26934316 DOI: 10.18632/Oncotarget.7753  0.612
2016 Karamboulas C, Bruce J, Qiu X, Meens J, Pereira K, Hyatt E, Huang SH, Xu W, Pugh T, Ailles L. Abstract B08: Patient-derived xenografts of oral squamous cell carcinoma: A model system for the identification of prognostic molecular signatures and for preclinical assessment of targeted therapies Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B08  0.387
2015 Bruce JP, Yip K, Bratman SV, Ito E, Liu FF. Nasopharyngeal Cancer: Molecular Landscape. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26351340 DOI: 10.1200/Jco.2015.60.7846  0.625
2015 Wong P, Hui A, Su J, Yue S, Haibe-Kains B, Gokgoz N, Xu W, Bruce J, Williams J, Catton C, Wunder JS, Andrulis IL, Gladdy R, Dickson B, O'Sullivan B, et al. Prognostic microRNAs modulate the RHO adhesion pathway: A potential therapeutic target in undifferentiated pleomorphic sarcomas. Oncotarget. PMID 25970788 DOI: 10.18632/Oncotarget.3926  0.498
2015 How C, Bruce J, So J, Pintilie M, Haibe-Kains B, Hui A, Clarke BA, Hedley DW, Hill RP, Milosevic M, Fyles A, Liu FF. Chromosomal instability as a prognostic marker in cervical cancer. Bmc Cancer. 15: 361. PMID 25944123 DOI: 10.1186/S12885-015-1372-0  0.672
2015 How C, Pintilie M, Bruce JP, Hui AB, Clarke BA, Wong P, Yin S, Yan R, Waggott D, Boutros PC, Fyles A, Hedley DW, Hill RP, Milosevic M, Liu FF. Developing a prognostic micro-RNA signature for human cervical carcinoma. Plos One. 10: e0123946. PMID 25880806 DOI: 10.1371/Journal.Pone.0123946  0.657
2015 Bruce JP, Hui AB, Shi W, Perez-Ordonez B, Weinreb I, Xu W, Haibe-Kains B, Waggott DM, Boutros PC, O'Sullivan B, Waldron J, Huang SH, Chen EX, Gilbert R, Liu FF. Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma. Oncotarget. 6: 4537-50. PMID 25738365 DOI: 10.18632/Oncotarget.3005  0.458
2015 Sepiashvili L, Bruce JP, Huang SH, O'Sullivan B, Liu FF, Kislinger T. Novel insights into head and neck cancer using next-generation "omic" technologies. Cancer Research. 75: 480-6. PMID 25589349 DOI: 10.1158/0008-5472.Can-14-3124  0.444
2015 Kogo R, How C, Chaudary N, Bruce J, Shi W, Hill RP, Zahedi P, Yip KW, Liu FF. The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget. 6: 1090-100. PMID 25473903 DOI: 10.18632/Oncotarget.2836  0.734
2015 Wilson MK, Bedard PL, Joshua AM, Mackay H, Butler MO, Dhani NC, Lheureux S, Martin-Lorente C, Rodriguez-Freixinos V, Clarke B, Shaw P, Milea A, Wang L, Kamel-Reid S, Stockley T, ... Bruce J, et al. Molecular profiling and targeted therapy in advanced endometrial cancer. Journal of Clinical Oncology. 33: 5589-5589. DOI: 10.1200/Jco.2015.33.15_Suppl.5589  0.313
2015 How C, Bruce J, So J, Pintilie M, Haibe-Kains B, Hui A, Clarke B, Hedley D, Hill R, Milosevic M, Fyles A, Yip KW, Liu F. Abstract 5297: Chromosomal instability as a prognostic marker in cervical cancer Cancer Research. 75: 5297-5297. DOI: 10.1158/1538-7445.Am2015-5297  0.663
2014 Bruce JP, Liu FF. MicroRNAs in nasopharyngeal carcinoma. Chinese Journal of Cancer. 33: 539-44. PMID 25367334 DOI: 10.5732/Cjc.014.10175  0.442
2013 Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, Bruce J, Mesci A, Korpela E, Vesprini D, Wong CS, Bristow RG, Liu FF, Liu SK. miRNA-95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Research. 73: 6972-86. PMID 24145350 DOI: 10.1158/0008-5472.Can-13-1657  0.609
2013 Lenarduzzi M, Hui AB, Yue S, Ito E, Shi W, Williams J, Bruce J, Sakemura-Nakatsugawa N, Xu W, Schimmer A, Liu FF. Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer. Plos One. 8: e74075. PMID 23991213 DOI: 10.1371/Journal.Pone.0074075  0.702
2013 Principe S, Hui AB, Bruce J, Sinha A, Liu FF, Kislinger T. Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery. Proteomics. 13: 1608-23. PMID 23505015 DOI: 10.1002/Pmic.201200533  0.545
2013 Hui AB, Lin A, Xu W, Waldron L, Perez-Ordonez B, Weinreb I, Shi W, Bruce J, Huang SH, O'Sullivan B, Waldron J, Gullane P, Irish JC, Chan K, Liu FF. Potentially prognostic miRNAs in HPV-associated oropharyngeal carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2154-62. PMID 23459718 DOI: 10.1158/1078-0432.Ccr-12-3572  0.497
2013 Costa PM, Cardoso AL, Nóbrega C, Pereira de Almeida LF, Bruce JN, Canoll P, Pedroso de Lima MC. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma. Human Molecular Genetics. 22: 904-18. PMID 23201752 DOI: 10.1093/Hmg/Dds496  0.412
2013 Shi W, Bruce J, Yan R, Liu F. Abstract 5289: Identification of basal-like subtype-specific MicroRNAs in lymph node negative breast cancer . Cancer Research. 73: 5289-5289. DOI: 10.1158/1538-7445.Am2013-5289  0.478
2012 Costa PM, Cardoso AL, Pereira de Almeida LF, Bruce JN, Canoll P, Pedroso de Lima MC. PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma. Human Molecular Genetics. 21: 5118-30. PMID 22922228 DOI: 10.1093/hmg/dds358  0.377
2011 Hui AB, Bruce JP, Alajez NM, Shi W, Yue S, Perez-Ordonez B, Xu W, O'Sullivan B, Waldron J, Cummings B, Gullane P, Siu L, Liu FF. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7539-50. PMID 22031094 DOI: 10.1158/1078-0432.Ccr-11-2102  0.494
2011 Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O'Sullivan B, Liu FF. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Research. 71: 2381-91. PMID 21385904 DOI: 10.1158/0008-5472.Can-10-2754  0.727
2010 Alajez NM, Shi W, Hui AB, Bruce J, Lenarduzzi M, Ito E, Yue S, O'Sullivan B, Liu FF. Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. Cell Death & Disease. 1: e85. PMID 21368858 DOI: 10.1038/Cddis.2010.64  0.722
Show low-probability matches.